NO20052475L - Acylderivater av 5-(2-(4-(1,2 benzotiazol-3-yl)-1-piperazinyl)etyl)-6-klor-1,3-dihydro-2H-indol-2-on med neuroleptisk aktivitet. - Google Patents
Acylderivater av 5-(2-(4-(1,2 benzotiazol-3-yl)-1-piperazinyl)etyl)-6-klor-1,3-dihydro-2H-indol-2-on med neuroleptisk aktivitet.Info
- Publication number
- NO20052475L NO20052475L NO20052475A NO20052475A NO20052475L NO 20052475 L NO20052475 L NO 20052475L NO 20052475 A NO20052475 A NO 20052475A NO 20052475 A NO20052475 A NO 20052475A NO 20052475 L NO20052475 L NO 20052475L
- Authority
- NO
- Norway
- Prior art keywords
- piperazinyl
- dihydro
- chloro
- ethyl
- acyl derivatives
- Prior art date
Links
- 125000002252 acyl group Chemical group 0.000 title abstract 2
- 230000000701 neuroleptic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42084302P | 2002-10-24 | 2002-10-24 | |
| PCT/IB2003/004519 WO2004037819A1 (en) | 2002-10-24 | 2003-10-13 | Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052475D0 NO20052475D0 (no) | 2005-05-23 |
| NO20052475L true NO20052475L (no) | 2005-07-25 |
Family
ID=32176638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052475A NO20052475L (no) | 2002-10-24 | 2005-05-23 | Acylderivater av 5-(2-(4-(1,2 benzotiazol-3-yl)-1-piperazinyl)etyl)-6-klor-1,3-dihydro-2H-indol-2-on med neuroleptisk aktivitet. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7019009B2 (de) |
| EP (1) | EP1556378B1 (de) |
| JP (1) | JP2006505578A (de) |
| KR (1) | KR100755625B1 (de) |
| CN (1) | CN100340557C (de) |
| AR (1) | AR041695A1 (de) |
| AT (1) | ATE383357T1 (de) |
| AU (1) | AU2003269331B2 (de) |
| BR (1) | BR0315516A (de) |
| CA (1) | CA2500485C (de) |
| CO (1) | CO5550441A2 (de) |
| CY (1) | CY1107300T1 (de) |
| DE (1) | DE60318602T2 (de) |
| DK (1) | DK1556378T3 (de) |
| ES (1) | ES2297200T3 (de) |
| MX (1) | MXPA05002734A (de) |
| NO (1) | NO20052475L (de) |
| NZ (1) | NZ566615A (de) |
| PL (1) | PL376721A1 (de) |
| PT (1) | PT1556378E (de) |
| RU (1) | RU2005112254A (de) |
| TW (1) | TW200418850A (de) |
| WO (1) | WO2004037819A1 (de) |
| ZA (1) | ZA200502109B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007517014A (ja) * | 2003-12-31 | 2007-06-28 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Ｎ−置換ピペリジン及びピペラジン誘導体 |
| US8431576B2 (en) | 2009-06-25 | 2013-04-30 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| JP5732453B2 (ja) * | 2009-06-25 | 2015-06-10 | アルカーメス ファーマ アイルランド リミテッド | Ｎｈ酸性化合物のプロドラッグ |
| US8592427B2 (en) * | 2010-06-24 | 2013-11-26 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| HK1215170A1 (zh) | 2012-11-14 | 2016-08-19 | The Johns Hopkins University | 治療精神分裂症的方法和組合物 |
| CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
| US5206366A (en) * | 1992-08-26 | 1993-04-27 | Pfizer Inc. | Process for preparing aryl piperazinyl-heterocyclic compounds |
| ATE254600T1 (de) * | 1996-02-13 | 2003-12-15 | Pfizer | Prodrogen von 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl ethyl)-6-chloro-1,3-dihydro-2h-indol- 2-on |
| JP4445133B2 (ja) * | 1998-08-20 | 2010-04-07 | 大日本住友製薬株式会社 | オキシインドール誘導体 |
-
2003
- 2003-10-13 NZ NZ566615A patent/NZ566615A/en not_active IP Right Cessation
- 2003-10-13 PT PT03751112T patent/PT1556378E/pt unknown
- 2003-10-13 CA CA2500485A patent/CA2500485C/en not_active Expired - Fee Related
- 2003-10-13 ES ES03751112T patent/ES2297200T3/es not_active Expired - Lifetime
- 2003-10-13 PL PL376721A patent/PL376721A1/pl not_active Application Discontinuation
- 2003-10-13 WO PCT/IB2003/004519 patent/WO2004037819A1/en not_active Ceased
- 2003-10-13 EP EP03751112A patent/EP1556378B1/de not_active Expired - Lifetime
- 2003-10-13 KR KR1020057006938A patent/KR100755625B1/ko not_active Expired - Fee Related
- 2003-10-13 MX MXPA05002734A patent/MXPA05002734A/es not_active Application Discontinuation
- 2003-10-13 DK DK03751112T patent/DK1556378T3/da active
- 2003-10-13 AU AU2003269331A patent/AU2003269331B2/en not_active Ceased
- 2003-10-13 RU RU2005112254/04A patent/RU2005112254A/ru not_active Application Discontinuation
- 2003-10-13 JP JP2004546256A patent/JP2006505578A/ja not_active Withdrawn
- 2003-10-13 BR BR0315516-1A patent/BR0315516A/pt not_active IP Right Cessation
- 2003-10-13 CN CNB2003801017404A patent/CN100340557C/zh not_active Expired - Fee Related
- 2003-10-13 AT AT03751112T patent/ATE383357T1/de not_active IP Right Cessation
- 2003-10-13 DE DE60318602T patent/DE60318602T2/de not_active Expired - Fee Related
- 2003-10-21 US US10/689,773 patent/US7019009B2/en not_active Expired - Fee Related
- 2003-10-22 AR ARP030103846A patent/AR041695A1/es unknown
- 2003-10-23 TW TW092129426A patent/TW200418850A/zh unknown
-
2005
- 2005-03-14 ZA ZA200502109A patent/ZA200502109B/en unknown
- 2005-04-22 CO CO05038502A patent/CO5550441A2/es not_active Application Discontinuation
- 2005-05-23 NO NO20052475A patent/NO20052475L/no not_active Application Discontinuation
-
2008
- 2008-03-12 CY CY20081100276T patent/CY1107300T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20052475D0 (no) | 2005-05-23 |
| CA2500485A1 (en) | 2004-05-06 |
| US20040138232A1 (en) | 2004-07-15 |
| PL376721A1 (pl) | 2006-01-09 |
| KR20050065618A (ko) | 2005-06-29 |
| DE60318602T2 (de) | 2009-01-15 |
| CY1107300T1 (el) | 2012-11-21 |
| ES2297200T3 (es) | 2008-05-01 |
| NZ566615A (en) | 2009-08-28 |
| AU2003269331B2 (en) | 2010-02-18 |
| CN100340557C (zh) | 2007-10-03 |
| DE60318602D1 (de) | 2008-02-21 |
| AR041695A1 (es) | 2005-05-26 |
| ZA200502109B (en) | 2006-05-31 |
| MXPA05002734A (es) | 2005-05-23 |
| CA2500485C (en) | 2010-03-23 |
| CN1705663A (zh) | 2005-12-07 |
| PT1556378E (pt) | 2008-02-21 |
| WO2004037819A1 (en) | 2004-05-06 |
| JP2006505578A (ja) | 2006-02-16 |
| AU2003269331A1 (en) | 2004-05-13 |
| US7019009B2 (en) | 2006-03-28 |
| EP1556378B1 (de) | 2008-01-09 |
| ATE383357T1 (de) | 2008-01-15 |
| KR100755625B1 (ko) | 2007-09-04 |
| TW200418850A (en) | 2004-10-01 |
| DK1556378T3 (da) | 2008-03-17 |
| BR0315516A (pt) | 2005-08-23 |
| HK1081185A1 (en) | 2006-05-12 |
| RU2005112254A (ru) | 2006-01-20 |
| CO5550441A2 (es) | 2005-08-31 |
| EP1556378A1 (de) | 2005-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG170785A1 (en) | Benzothiazoles having histamine h3 receptor activity | |
| HUP9902808A2 (hu) | 5-(2-(4-(1,2-Benzizotiazol-3-il)-1-piperazinil)-etil)-6-klór-1,3-dihidro-2-(1H)-indol-2-on (ziprazidon) mezilát-trihidrát sói, a vegyületek előállítása és dopamin D2 antagonistaként történő alkalmazása | |
| MY119997A (en) | Mesylate dihydrate salts of 5-(2-(4-(1, 2-benzisothiazol-3-yl) -1-piperazinyl)-6-chloro-1, 3- dihydro-2h-indol-2-one | |
| ATE303987T1 (de) | Phenoxypropylamin-derivate | |
| EA200401136A1 (ru) | Предназначенная для перорального применения лекарственная форма для этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1h-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его солей | |
| IL202047A (en) | Trans-4- {2- [4 [(3,2-dichlorophenyl) -piperazine-1-yl] -ethyl} - n-n-dimethylcarbamoyl-cyclohexylamine for use in the treatment of schizophrenia | |
| GEP20135731B (en) | Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethyl carbamoyl-cyclohexylamine for acute mania treatment | |
| CY1107300T1 (el) | Ακυλικα παραγωγα της 5-(2-(4-(1,2-βενζισοθειαζολ-3-υλο)-1-πιπεραζινυλ)αιθυλο)-6-χλωρο-1,3-διυδρο-2h-ινδολ-2-ονης με νευροληπτικη δραστικοτητα | |
| DK0790236T3 (da) | Prolægemidler af 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-on | |
| DK1461326T3 (da) | Benzothiazol og benzoxazol-4,7 -dion-derivater og anvendelse heraf som inhibitorer for cdc25-phosphataser | |
| NI200600270A (es) | Una composición farmacéutica antimicobacteriana que comprende un farmaco antituberculosis | |
| UY26568A1 (es) | Nuevos derivados de amidas heterocíclicas | |
| DE50013571D1 (de) | Arzneimittel zur behandlung von neuropathien | |
| NO20013408L (no) | Anvendelse av 2-substituerte 1,2-benzisotiazol-derivater og 3- substituerte tetrahydropyridopyrimidinon-derivater for profylakseog terapi av cerebral ischemi | |
| MEP37108A (en) | Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate | |
| DK1421086T3 (da) | 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet | |
| NO20075600L (no) | Profylaktisk eller terapeutisk middel mot nattlig atferdsforstyrrelse assosiert med demens | |
| NO20025031L (no) | Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasöytiske midler | |
| ATE412416T1 (de) | Indolin-2-one-pyridin-derivate, herstellung und therapeutische verwendung dafür | |
| DK1409490T3 (da) | 2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning | |
| DE60333268D1 (de) | Hydroxymorpholinonderivat und dessen medizinische verwendung | |
| MY109504A (en) | Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride | |
| ES2083319A1 (es) | Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona. | |
| UA101341C2 (ru) | Терапевтические применения соединений, которые имеют комбинированную активность в отношении sert, 5-нт3 и 5-нт1a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |